
GC19326
Senexin B
Also known as 4-[2-[6-(4-methylpiperazine-1-carbonyl)naphthalen-2-yl]ethylamino]quinazoline-6-carbonitrile
Senexin B is a potent, highly water-soluble and bioavailable CDK8/19 inhibitor, with Kds of 140 nM for CDK8 and 80 nM for CDK19
ChemicalCAS1449228-40-3MW450.53FormulaC27H26N6O
- CAS number
- 1449228-40-3
- Molecular weight
- 450.53
- Formula
- C27H26N6O
- Solubility
- DMSO : 6 mg/mL (13·32 mM)
- InChIKey
- VNADJTWHOAMTLY-UHFFFAOYSA-N
- Catalogue number
- GC19326
- Brand
- GLPBIO
Computed properties PubChem CID 71661259 · XLogP 4.1 · TPSA 85.2 Ų · H-bond donors 1
- XLogP
- 4.1
- TPSA
- 85.2 Ų
- H-bond donors
- 1
- H-bond acceptors
- 6
- Rotatable bonds
- 5
- Heavy atoms
- 34
SMILES CN1CCN(CC1)C(=O)C2=CC3=C(C=C2)C=C(C=C3)CCNC4=NC=NC5=C4C=C(C=C5)C#N
Computed descriptors from PubChem (CID 71661259), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il